id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3287-0006,FDA,FDA-2019-E-3287,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-01-13T05:00:00Z,2025,1,2025-01-13T05:00:00Z,,2025-01-13T20:43:55Z,,0,0,09000064868b7bd4
FDA-2019-E-3287-0005,FDA,FDA-2019-E-3287,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-12-29T05:00:00Z,2023,12,2023-12-29T05:00:00Z,,2023-12-29T14:14:00Z,,0,0,0900006486365c60
FDA-2019-E-3287-0004,FDA,FDA-2019-E-3287,Determination of Regulatory Review Period for Purposes of Patent Extension; Copiktra,Notice,Determinations,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,2024-02-21T04:59:59Z,2023-12-22T15:41:59Z,2023-28244,0,0,090000648635121b
FDA-2019-E-3287-0003,FDA,FDA-2019-E-3287,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2019-12-02T05:00:00Z,2019,12,2019-12-02T05:00:00Z,,2019-12-02T18:30:09Z,,0,0,09000064841d9a75
FDA-2019-E-3287-0001,FDA,FDA-2019-E-3287,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T11:54:26Z,,0,0,0900006483d6ce84
FDA-2019-E-3287-0002,FDA,FDA-2019-E-3287,"Patent Extension Application from Goodwin Proctor LLP (on behalf of Verastem, Inc.)",Other,Application,2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T12:44:18Z,,0,0,0900006483d6ce85